AllergyTablets Information
More articles below:
'Off-the-Charts' Pollen Counts Bring Misery to Millions
Some Allergy Sufferers Can Skip the Sneezing Season
Meat Might Be Behind Many Unidentified Allergic Reactions
Household Dirt Won't Raise Asthma Risk in Infants
Kids' Peanut Allergies Might Be Tamed
Blood Test Might Sort Out Milk Allergies
Xyzal Approved for Younger Kids
TUESDAY, Aug. 25 (HealthDay News) -- The antihistamine Xyzal (levocetirizine dihydrochloride) has been approved for children aged six months and older for indoor allergies and hives, drug makers UCB and Sanofi-Aventis said.
The medication, available as a liquid or pill, had been approved previously for people aged six years and older. The expanded approval also sanctions the drug's use to treat outdoor allergies in children aged two years and older.
Side effects of the medication may include fatigue, sore throat and dry mouth. Younger children may have additional adverse effects including fever, diarrhea, vomiting, ear infections and constipation, the drug makers said in a news release.
More information
The FDA has more information about this drug's approval history.
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
